Medicare Enrolled
Dr. Carlos Quintana, MD
Neurology · San Francisco, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Quintana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quintana?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Quintana
Dr. Carlos Quintana is a neurology specialist in San Francisco, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Quintana performed 1,083 Medicare services across 625 unique beneficiaries.
Between the years covered by Open Payments, Dr. Quintana received a total of $13,870 from 64 pharmaceutical and/or device companies across 842 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Quintana is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in CA
$13,870 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,083
Medicare services
Top 30% in CA for neurology
625
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
446 | $108 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
183 | $13 | $35 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
151 | $153 | $265 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
99 | $143 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $68 | $130 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
35 | $82 | $275 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $105 | $240 |
| Head repositioning exercises for dizziness A series of exercises performed to reposition the head, used to treat dizziness. The procedure is administered on a daily basis. |
22 | $38 | $115 |
| New patient office visit, complex (60-74 min) | 22 | $179 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
22 | $69 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $125 | $400 |
| EEG monitoring, 2-12 hours with review This procedure records brain wave activity for 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
13 | $90 | $245 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,870
Total received (2018-2024)
Avg $1,981/year across 7 years
Top 20% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
842
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,857 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,455
2023
$3,404
2022
$2,030
2021
$1,856
2020
$1,351
2019
$868
2018
$907
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$536
ABBVIE INC.
$463
MDD US Operations, LLC
$351
Lilly USA, LLC
$282
SK Life Science, Inc.
$278
Lundbeck LLC
$243
Neurelis, Inc.
$225
PFIZER INC.
$165
UCB, Inc.
$156
Teva Pharmaceuticals USA, Inc.
$148
Amneal Pharmaceuticals LLC
$142
Amgen Inc.
$82
Kyowa Kirin, Inc.
$57
ACADIA Pharmaceuticals Inc
$43
VERTEX PHARMACEUTICALS INCORPORATED
$33
Alexion Pharmaceuticals, Inc.
$32
Janssen Pharmaceuticals, Inc
$28
Janssen Scientific Affairs, LLC
$27
ARGENX US, INC.
$26
Eisai Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$25
Acorda Therapeutics, Inc
$23
Boston Scientific Corporation
$23
Agios Pharmaceuticals, Inc.
$22
SCILEX PHARMACEUTICALS INC.
$21
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$1,564
SK Life Science, Inc.
$1,504
ABBVIE INC.
$1,057
Teva Pharmaceuticals USA, Inc.
$941
UCB, Inc.
$858
MDD US Operations, LLC
$727
Lundbeck LLC
$573
Sunovion Pharmaceuticals Inc.
$569
Neurelis, Inc.
$505
Lilly USA, LLC
$471
Biohaven Pharmaceutical Holding Company Ltd.
$398
PFIZER INC.
$382
Amgen Inc.
$381
Sumitomo Pharma America, Inc.
$374
Amneal Pharmaceuticals LLC
$262
Allergan Inc.
$227
Almatica Pharma LLC
$218
Kyowa Kirin, Inc.
$213
ACADIA Pharmaceuticals Inc
$209
Avanir Pharmaceuticals, Inc.
$166
Eisai Inc.
$166
Novartis Pharmaceuticals Corporation
$154
IMPEL PHARMACEUTICALS INC.
$147
Biohaven Pharmaceuticals, Inc.
$142
Merck Sharp & Dohme Corporation
$135
Alexion Pharmaceuticals, Inc.
$124
Scilex Pharmaceuticals Inc.
$101
Biogen, Inc.
$87
E.R. Squibb & Sons, L.L.C.
$81
Otsuka America Pharmaceutical, Inc.
$80
GlaxoSmithKline, LLC.
$70
Arbor Pharmaceuticals, Inc.
$53
Supernus Pharmaceuticals, Inc.
$53
Janssen Pharmaceuticals, Inc
$52
Takeda Pharmaceuticals U.S.A., Inc.
$50
IDORSIA PHARMACEUTICALS US INC
$48
EMD Serono, Inc.
$44
Endo Pharmaceuticals Inc.
$42
Acorda Therapeutics, Inc
$41
BioDelivery Sciences International, Inc.
$39
Allergan, Inc.
$38
AstraZeneca Pharmaceuticals LP
$37
AbbVie Inc.
$37
VERTEX PHARMACEUTICALS INCORPORATED
$33
US WorldMeds, LLC
$32
Mallinckrodt Hospital Products Inc.
$29
Janssen Scientific Affairs, LLC
$27
ARGENX US, INC.
$26
JAZZ PHARMACEUTICALS INC.
$24
Boston Scientific Corporation
$23
ASSERTIO THERAPEUTICS, Inc.
$23
Agios Pharmaceuticals, Inc.
$22
Impax Laboratories, Inc.
$21
Collegium Pharmaceutical, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$21
UPSHER-SMITH LABORATORIES LLC
$20
Merck Sharp & Dohme LLC
$20
Bausch Health US, LLC
$19
OWP Pharmaceuticals, Inc.
$19
Pernix Therapeutics Holdings, Inc.
$16
GENZYME CORPORATION
$16
ARBOR PHARMACEUTICALS, INC.
$14
Adamas Pharmaceuticals, Inc.
$12
Assertio Therapeutics, Inc.
$12
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Amitiza · Apokyn · Austedo XR · BELBUCA · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · Belbuca · Briviact · COMIRNATY · COPAXONE · DUOPA · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · Edarbi · Fycompa · GOCOVRI · GRALISE · Gocovri · Gralise · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MIGRANAL · Mavenclad · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONGENTYS · Ongentys · PAXLOVID · Ponvory · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Rebif · SHINGRIX · SOLIRIS · SUNOSI · Soliris · Subvenite · TOSYMRA · TRELEGY ELLIPTA · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYEPTI · VYVGART HYTRULO · Vimpat · XARELTO · XCOPRI · Xadago · ZOHYDRO ER · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
232
Per 100K population
27.7
County median income
$141,446
Nearest hospital
CALIFORNIA PACIFIC MEDICAL CTR-DAVIES CAMPUS HOSP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Quintana is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Quintana experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Quintana performed 446 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quintana receive payments from pharmaceutical companies?
Yes. Dr. Quintana received a total of $13,870 from 64 companies across 842 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quintana's costs compare to other neurologists in San Francisco?
Dr. Quintana's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quintana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in San Francisco
Browse neurologists in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology